Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

Université Paris Est Créteil, Creteil, France.

Survival: monthsCountry:France
Toxiciy Grade:5City/State/Province:Creteil
Treatments:Biologic therapyHospital:Université Paris Est Créteil
Drugs:Journal:Link
Date:Mar 2012

Description:

Patients:
This phase II study involved 25 advanced hepatocellular carcinoma patients who were not previously treated with any systemic therapy. The median patient age was 60.2 years and 23 of the patients were male.

Treatment:
Patients were treated with sirolimus, which is a biologic therapy agent that inhibits a protein called mTOR and interferes with tumor cell growth.

Toxicities:
There were two treatment-related deaths due to infection reported. Grade 3 thrombocytopenia and inflammation of the gastrointestinal tract were also reported.

Results:
The median overall survival was 6.1 months.

Correspondence: Dr. Thomas Decaens; email: [email protected]



Back